Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Epidemiol Infect ; 151: e95, 2023 05 24.
Artículo en Inglés | MEDLINE | ID: mdl-37222136

RESUMEN

Toxoplasmosis caused by the protozoan parasite Toxoplasma gondii occurs worldwide. Infections range from asymptomatic to life-threatening. T. gondii infection is acquired either via bradyzoites in meat or via oocysts in the environment, but the relative importance of these path ways and the different sources remains unclear. In this study, possible risk factors for toxoplasmosis in the Netherlands were investigated. A case-control study was conducted including persons with recent infection and individuals with a negative test result for IgM and IgG for T. gondii between July 2016 and April 2021. A total of 48 cases and 50 controls completed the questionnaire. Food history and environmental exposure were compared using logistic regression. Consumption of different meats was found to be associated with recent infection. In the multivariable model, adjusted for age, gender, and pregnancy, consumption of large game meat (adjusted odds ratio (aOR) 8.2, 95% confidence interval 1.6-41.9) and sometimes (aOR 4.1, 1.1-15.3) or never (aOR 15.9, 2.2-115.5) washing hands before food preparation remained. These results emphasize the value of the advice to be careful with the consumption of raw and undercooked meat. Good hand hygiene could also be promoted in the prevention of T. gondii infection.


Asunto(s)
Toxoplasma , Toxoplasmosis , Embarazo , Femenino , Humanos , Países Bajos/epidemiología , Estudios de Casos y Controles , Toxoplasmosis/epidemiología , Factores de Riesgo
2.
Ned Tijdschr Geneeskd ; 1622018 08 30.
Artículo en Holandés | MEDLINE | ID: mdl-30212003

RESUMEN

BACKGROUND: On returning from a period in a country where tuberculosis is endemic, e.g. a medical internship abroad, screening for tuberculosis takes place. The tuberculin skin test (Mantoux test) and the interferon-γ release assay test are available for this purpose. CASE DESCRIPTION: We describe a 23-year-old female medical intern who was treated preventively with a tuberculostatic drug due to a latent tuberculosis infection (LTBI) following an internship in India. This treatment was prematurely discontinued due to increased transaminases (ALT, AST) and physical side effects that impacted negatively on her general wellbeing and on her ability to function during her later internships. CONCLUSION: Long-term preventive treatment for a health care professional with an LTBI is often indicated. However, this treatment can have negative side effects.


Asunto(s)
Antituberculosos/efectos adversos , Internado y Residencia , Tuberculosis Latente/prevención & control , Femenino , Humanos , India , Tuberculosis Latente/diagnóstico , Adulto Joven
3.
J Clin Microbiol ; 54(10): 2464-9, 2016 10.
Artículo en Inglés | MEDLINE | ID: mdl-27413193

RESUMEN

Vancomycin-resistant enterococci (VRE) are an important cause of health care-acquired infections (HAIs). Studies have shown that active surveillance of high-risk patients for VRE colonization can aid in reducing HAIs; however, these screens generate a significant cost to the laboratory and health care system. Digital imaging capable of differentiating negative and "nonnegative" chromogenic agar can reduce the labor cost of these screens and potentially improve patient care. In this study, we evaluated the performance of the WASPLab Chromogenic Detection Module (CDM) (Copan, Brescia, Italy) software to analyze VRE chromogenic agar and compared the results to technologist plate reading. Specimens collected at 3 laboratories were cultured using the WASPLab CDM and plated to each site's standard-of-care chromogenic media, which included Colorex VRE (BioMed Diagnostics, White City, OR) or Oxoid VRE (Oxoid, Basingstoke, United Kingdom). Digital images were scored using the CDM software after 24 or 40 h of growth, and all manual reading was performed using digital images on a high-definition (HD) monitor. In total, 104,730 specimens were enrolled and automation agreed with manual analysis for 90.1% of all specimens tested, with sensitivity and specificity of 100% and 89.5%, respectively. Automation results were discordant for 10,348 specimens, and all discordant images were reviewed by a laboratory supervisor or director. After a second review, 499 specimens were identified as representing missed positive cultures falsely called negative by the technologist, 1,616 were identified as containing borderline color results (negative result but with no package insert color visible), and 8,234 specimens were identified as containing colorimetric pigmentation due to residual matrix from the specimen or yeast (Candida). Overall, the CDM was accurate at identifying negative VRE plates, which comprised 84% (87,973) of the specimens in this study.


Asunto(s)
Automatización de Laboratorios/métodos , Técnicas Bacteriológicas/métodos , Compuestos Cromogénicos/metabolismo , Medios de Cultivo/química , Infecciones por Bacterias Grampositivas/diagnóstico , Tamizaje Masivo/métodos , Enterococos Resistentes a la Vancomicina/aislamiento & purificación , Errores Diagnósticos , Infecciones por Bacterias Grampositivas/microbiología , Humanos , Procesamiento de Imagen Asistido por Computador/métodos , Imagen Óptica/métodos , Sensibilidad y Especificidad
4.
J Clin Microbiol ; 50(4): 1437-9, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22238435

RESUMEN

Five methods were compared to determine the most accurate method for identification of coagulase-negative staphylococci (CoNS) (n = 142 strains). Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) showed the best results for rapid and accurate CoNS differentiation (99.3% of strains correctly identified). An alternative to this approach could be Vitek2 combined with partial tuf gene sequencing (100% of strains correctly identified when both methods are performed simultaneously).


Asunto(s)
Coagulasa/genética , Tipificación Molecular , Staphylococcus/clasificación , Genotipo , Fenotipo , Proteómica , ARN Bacteriano/genética , ARN Ribosómico 16S/genética , Estándares de Referencia , Análisis de Secuencia de ADN/normas , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción/normas , Staphylococcus/enzimología , Staphylococcus/genética
5.
Lancet Infect Dis ; 11(5): 372-80, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21420908

RESUMEN

BACKGROUND: Previously, we assessed selective digestive tract decontamination (SDD) and selective oropharyngeal decontamination (SOD) on survival and prevention of bacteraemia in patients in intensive-care units. In this analysis, we aimed to assess effectiveness of these interventions for prevention of respiratory tract colonisation and bacteraemia with highly resistant microorganisms acquired in intensive-care units. METHODS: We did an open-label, clustered group-randomised, crossover study in 13 intensive-care units in the Netherlands between May, 2004, and July, 2006. Participants admitted to intensive-care units with an expected duration of mechanical ventilation of more than 48 h or an expected stay of more than 72 h received SOD (topical tobramycin, colistin, and amphotericin B in the oropharynx), SDD (SOD antibiotics in the oropharynx and stomach plus 4 days' intravenous cefotaxime), or standard care. The computer-randomised order of study regimens was applied by an independent clinical pharmacist who was masked to intensive-care-unit identity. We calculated crude odds ratios (95% CI) for rates of bacteraemia or respiratory tract colonisation with highly resistant microorganisms in patients who stayed in intensive-care units for more than 3 days (ie, acquired infection). This trial is registered at http://isrctn.org, number ISRCTN35176830. FINDINGS: Data were available for 5927 (>99%) of 5939 patients, of whom 5463 (92%) were in intensive-care units for more than 3 days. 239 (13%) of 1837 patients in standard care acquired bacteraemia after 3 days, compared with 158 (9%) of 1758 in SOD (odds ratio 0·66, 95% CI 0·53-0·82), and 124 (7%) of 1868 in SDD (0·48, 0·38-0·60). Eight patients acquired bacteraemia with highly resistant microorganisms during SDD, compared with 18 patients (with 19 episodes) during standard care (0·41, 0·18-0·94; rate reduction [RR] 59%, absolute risk reduction [ARR] 0·6%) and 20 during SOD (0·37, 0·16-0·85; RR 63%, ARR 0·7%). Of the patients staying in intensive-care units for more than 3 days, we obtained endotracheal aspirate cultures for 881 (49%) patients receiving standard care, 886 (50%) receiving SOD, and 828 (44%) receiving SDD. 128 (15%) patients acquired respiratory tract colonisation with highly resistant microorganisms during standard care, compared with 74 (8%) during SDD (0·58, 0·43-0·78; RR 38%, ARR 5·5%) and 88 (10%) during SOD (0·65, 0·49-0·87; RR 32%, ARR 4·6%). Acquired respiratory tract colonisation with Gram-negative bacteria or cefotaxime-resistant and colistin-resistant pathogens was lowest during SDD. INTERPRETATION: Widespread use of SDD and SOD in intensive-care units with low levels of antibiotic resistance is justified. FUNDING: None.


Asunto(s)
Antibacterianos/farmacología , Antifúngicos/farmacología , Descontaminación/métodos , Farmacorresistencia Bacteriana , Tracto Gastrointestinal/microbiología , Orofaringe/microbiología , Bacterias/efectos de los fármacos , Estudios Cruzados , Farmacorresistencia Fúngica , Humanos , Unidades de Cuidados Intensivos
6.
Am J Respir Crit Care Med ; 181(5): 452-7, 2010 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-19965807

RESUMEN

RATIONALE: Selective digestive tract decontamination (SDD) and selective oropharyngeal decontamination (SOD) eradicate gram-negative bacteria (GNB) from the intestinal and respiratory tract in intensive care unit (ICU) patients, but their effect on antibiotic resistance remains controversial. OBJECTIVES: We quantified the effects of SDD and SOD on bacterial ecology in 13 ICUs that participated in a study, in which SDD, SOD, or standard care was used during consecutive periods of 6 months (de Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS, van der Hoeven JG, Pickkers P, Bogaers-Hofman D, van der Meer NJ, et al. N Engl J Med 2009;360:20-31). METHODS: Point prevalence surveys of rectal and respiratory samples were performed once monthly in all ICU patients (receiving or not receiving SOD/SDD). Effects of SDD on rectal, and of SDD/SOD on respiratory tract, carriage of GNB were determined by comparing results from consecutive point prevalence surveys during intervention (6 mo for SDD and 12 mo for SDD/SOD) with consecutive point prevalence data in the pre- and postintervention periods. MEASUREMENTS AND MAIN RESULTS: During SDD, average proportions of patients with intestinal colonization with GNB resistant to either ceftazidime, tobramycin, or ciprofloxacin were 5, 7, and 7%, and increased to 15, 13, and 13% postintervention (P < 0.05). During SDD/SOD resistance levels in the respiratory tract were not more than 6% for all three antibiotics but increased gradually (for ceftazidime; P < 0.05 for trend) during intervention and to levels of 10% or more for all three antibiotics postintervention (P < 0.05). CONCLUSIONS: SOD and SDD have marked effects on the bacterial ecology in an ICU, with rising ceftazidime resistance prevalence rates in the respiratory tract during intervention and a considerable rebound effect of ceftazidime resistance in the intestinal tract after discontinuation of SDD.


Asunto(s)
Profilaxis Antibiótica , Farmacorresistencia Bacteriana/efectos de los fármacos , Bacterias Gramnegativas/efectos de los fármacos , Infecciones por Bacterias Gramnegativas/prevención & control , Unidades de Cuidados Intensivos , Infecciones del Sistema Respiratorio/prevención & control , Antibacterianos/uso terapéutico , Profilaxis Antibiótica/efectos adversos , Ceftazidima/uso terapéutico , Ciprofloxacina/uso terapéutico , Infección Hospitalaria/tratamiento farmacológico , Infección Hospitalaria/microbiología , Infección Hospitalaria/prevención & control , Infecciones por Bacterias Gramnegativas/tratamiento farmacológico , Infecciones por Bacterias Gramnegativas/microbiología , Humanos , Estudios Longitudinales , Recto/microbiología , Sistema Respiratorio/microbiología , Infecciones del Sistema Respiratorio/tratamiento farmacológico , Infecciones del Sistema Respiratorio/microbiología , Tobramicina/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA